Clinical Trial

Characteristics of NAFLD Among Type 2 Diabetes Patients

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 9, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Type 2 diabetes patients have a high risk of developing NAFLD. This was confirmed during previous research, a high prevalence of NAFLD among type 2 diabetes mellitus patients was found. The investigators want to determine the characteristics of this population.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-08-09; most recent amendment 2025-07-02.
Status change: Recruiting → Active, Not Recruiting 2024-09-23
Trial Details
NCT Number NCT04999124
Lead Sponsor Ziekenhuis Oost-Limburg
Conditions Non-Alcoholic Fatty Liver Disease, Type2 Diabetes
Enrollment 3,000 participants
Start Date 2020-01-01
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-09